Purinostat Mesylate

Purinostat Mesylate · Chengdu Zenitar Biomedical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Purinostat Mesylate, covering 2025-04-02 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma [Phase 2]

See pricing